-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EXIBEdpuqWndATYuzUg2TCPZYO8R63Oof7zVdHjJ9hPX8p8ofubd/9Z8zIwICpLK sLGPzLzr5fmvmg/+f20Bow== 0001472974-10-000002.txt : 20100616 0001472974-10-000002.hdr.sgml : 20100616 20100615184717 ACCESSION NUMBER: 0001472974-10-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100616 DATE AS OF CHANGE: 20100615 EFFECTIVENESS DATE: 20100616 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Onpharma Inc. CENTRAL INDEX KEY: 0001472974 IRS NUMBER: 208678678 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-134841 FILM NUMBER: 10899163 BUSINESS ADDRESS: STREET 1: 200 S SANTA CRUZ AVE STREET 2: SUITE 100 CITY: LOS GATOS STATE: CA ZIP: 95030 BUSINESS PHONE: 408-335-6790 MAIL ADDRESS: STREET 1: 200 S SANTA CRUZ AVE STREET 2: SUITE 100 CITY: LOS GATOS STATE: CA ZIP: 95030 FORMER COMPANY: FORMER CONFORMED NAME: Monterey Devices, Inc. DATE OF NAME CHANGE: 20090923 D/A 1 primary_doc.xml X0704 D/A LIVE 0001472974 Onpharma Inc. 200 S SANTA CRUZ AVE SUITE 100 LOS GATOS CA CALIFORNIA 95030 408-335-6790 CALIFORNIA Monterey Medical, Inc. Monterey Devices, Inc. Corporation true 2006 Matthew Stepovich c/o Onpharma Inc. 200 S Santa Cruz Ave, Ste 100 Los Gatos CA CALIFORNIA 95030 Executive Officer Director Michael Falkel c/o Onpharma Inc. 200 S Santa Cruz Ave, Ste 100 Los Gatos CA CALIFORNIA 95030 Director Michael Rose c/o Onpharma Inc. 200 S Santa Cruz Ave, Ste 100 Los Gatos CA CALIFORNIA 95030 Director Michael Parsons c/o Onpharma Inc. 200 S Santa Cruz Ave, Ste 100 Los Gatos CA CALIFORNIA 95030 Executive Officer Other Decline to Disclose 06 true 0001472974-09-000002 2009-12-04 false true false 1 6999999 5584041 1415958 Total offering amount: $6,999,999.85, Total amount sold: $5,584,041.74 , Total remaining to be sold: $1,415,958.11 false 145 0 0 0 false Onpharma Inc. Matthew Stepovich Matthew Stepovich President & CEO 2010-06-15 -----END PRIVACY-ENHANCED MESSAGE-----